CA Patent

CA2954016A1 — Methods for treating hypotension

Assigned to La Jolla Pharmaceutical Co · Expires 2016-01-14 · 10y expired

What this patent protects

The present disclosure relates to the use of angiotensin II in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant: hypotension.

USPTO Abstract

The present disclosure relates to the use of angiotensin II in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant: hypotension.

Drugs covered by this patent

Patent Metadata

Patent number
CA2954016A1
Jurisdiction
CA
Classification
—
Expires
2016-01-14
Drug substance claim
No
Drug product claim
No
Assignee
La Jolla Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.